Predictive value of circulating immature cell counts in peripheral blood for timing of peripheral blood progenitor cell collection after G-CSF plus chemotherapy-induced mobilization

Transfusion

Volumn 42, Issue 11, 2002, Pages 1514-1522

  Kozuka, Teruhiko ^a,b,c   Ikeda, Kazuma ^a,b,c   Teshima, Takanori ^a,b,c   Kojima, Kensuke ^a,b,c   Matsuo, Keitaro ^a,b,c   Bessho, Akihiro ^a,b,c   Sunami, Kazutaka ^a,b,c   Hiramatsu, Yasushi ^a,b,c   Maeda, Yoshinobu ^a,b,c   Noguchi, Toshio ^a,b,c   Yamamoto, Kazuhiko ^a,b,c   Fujii, Nobuharu ^a,b,c   Imai, Toshi ^a,b,c   Takenaka, Katsuto ^a,b,c   Shinagawa, Katsuji ^a,b,c   Ishimaru, Fumihiko ^a,b,c   Niiya, Kenji ^a,b,c   Koide, Norio ^a,b,c   Tanimoto, Mitsune ^a,b,c   Harada, Mine ^a,b,c  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; G IDEA PROTOCOL; G-IDEA PROTOCOL; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; BLOOD; BLOOD CELL COUNT; CELL AGING; CYTOLOGY; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; LEUKAPHERESIS; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEOPLASM; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PREDICTION AND FORECASTING; ROC CURVE; STEM CELL MOBILIZATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD CELL COUNT; CELL AGING; COMBINED MODALITY THERAPY; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; IFOSFAMIDE; LEUKAPHERESIS; MALE; MIDDLE AGED; NEOPLASMS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; ROC CURVE; TRANSPLANTATION, AUTOLOGOUS;

EID: 18744387490     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2002.00218.x     Document Type: Article

References (36)

1. 1 Perez‐Simon JA, Caballero MD, Corral M, et al. Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation. Transfusion 1998 ; 38: 385 ‐ 91.
2. 2 Bensinger W, Singer J, Appelbaum F, et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993 ; 81: 3158 ‐ 63.
3. 3 Bender JG, To LB, Williams S, Schwartzberg LS. Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992 ; 1: 329 ‐ 41.
4. 4 Bensinger WI, Longin K, Appelbaum F, et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG‐CSF). an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994 ; 87: 825 ‐ 31.
5. 5 Watts MJ, Sullivan AM, Leverett D, et al. Back‐up bone marrow is frequently ineffective in patients with poor peripheral‐blood stem‐cell mobilization. J Clin Oncol 1998 ; 16: 1554 ‐ 60.
6. 6 Gandhi MK, Jestice K, Scott MA, et al. The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients. Bone Marrow Transplant 1999 ; 23: 9 ‐ 13.
7. 7 Stewart AK, Imrie K, Keating A, et al. Optimizing the CD34+ and CD34+Thy‐1+ stem cell content of peripheral blood collections. Exp Hematol 1995 ; 23: 1619 ‐ 27.
8. 8 Demirer T, Buckner CD, Appelbaum FR, et al. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony‐stimulating factor‐mobilized peripheral blood stem cells in patients with acute myelogenous leukemia. Bone Marrow Transplant 1995 ; 15: 915 ‐ 22.
9. 9 Ho AD, Gluck S, Germond C, et al. Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte‐macrophage colony‐stimulating factor for autologous transplantation in advanced breast cancer. Leukemia 1993 ; 7: 1738 ‐ 46.
10. 10 Elliott C, Samson DM, Armitage S, et al. When to harvest peripheral‐blood stem cells after mobilization therapy: prediction of CD34‐positive cell yield by preceding day CD34‐positive concentration in peripheral blood. J Clin Oncol 1996 ; 14: 970 ‐ 3.
11. 11 Schots R, Van Riet I, Damiaens S, et al. The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplant 1996 ; 17: 509 ‐ 15.
12. 12 Passos‐Coelho JL, Braine HG, Davis JM, et al. Predictive factors for peripheral‐blood progenitor‐cell collections using a single large‐volume leukapheresis after cyclophosphamide and granulocyte‐macrophage colony‐stimulating factor mobilization. J Clin Oncol 1995 ; 13: 705 ‐ 14.
13. 13 Yu J, Leisenring W, Bensinger WI, et al. The predictive value of white cell or CD34+ cell count in the peripheral blood for timing apheresis and maximizing yield. Transfusion 1999 ; 39: 442 ‐ 50.
14. 14 Bensinger W, Appelbaum F, Rowley S, et al. Factors that influence collection and engraftment of autologous peripheral‐blood stem cells. J Clin Oncol 1995 ; 13: 2547 ‐ 55.
15. 15 Siena S, Bregni M, Brando B, et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991 ; 77: 400 ‐ 9.
16. 16 Haas R, Mohle R, Fruhauf S, et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994 ; 83: 3787 ‐ 94.
17. 17 Watts MJ, Sullivan AM, Jamieson E, et al. Progenitor‐cell mobilization after low‐dose cyclophosphamide and granulocyte colony‐stimulating factor: an analysis of progenitor‐cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma. J Clin Oncol 1997 ; 15: 535 ‐ 46.
18. 18 Dreger P, Marquardt P, Haferlach T, et al. Effective mobilisation of peripheral blood progenitor cells with ‘Dexa‐BEAM’ and G‐CSF: timing of harvesting and composition of the leukapheresis product. Br J Cancer 1993 ; 68: 950 ‐ 7.
19. 19 Yu J, Leisenring W, Fritschle W, et al. Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34+ cell yield in the apheresis collection. Bone Marrow Transplant 2000 ; 25: 1157 ‐ 64.
20. 20 Mougi H, Shinmyozu K, Osame M. Determining the optimal time for peripheral blood stem cell harvest by detecting immature cells (immature leukocytes and immature reticulocytes) using two newly developed automatic cell analyzers. Int J Hematol 1997 ; 66: 303 ‐ 13.
21. 21 D'Arena G, Musto P, Di Mauro L, et al. Predictive parameters for mobilized peripheral blood CD34+ progenitor cell collection in patients with hematological malignancies. Am J Hematol 1998 ; 58: 255 ‐ 62.
22. 22 Gowans ID, Hepburn MD, Clark DM, et al. The role of the Sysmex SE9000 immature myeloid index and Sysmex R2000 reticulocyte parameters in optimizing the timing of peripheral blood stem cell harvesting in patients with lymphoma and myeloma. Clin Lab Haematol 1999 ; 21: 331 ‐ 6.
23. 23 Park KU, Kim SH, Suh C, et al. Correlation of hematopo‐ ietic progenitor cell count determined by the SE‐ automated hematology analyzer with CD34 (+) cell count by flow cytometry in leukapheresis products. Am J Hematol 2001 ; 67: 42 ‐ 7.
24. 24 Pollard Y, Watts MJ, Grant D, et al. Use of the haemopoietic progenitor cell count of the Sysmex SE‐9500 to refine apheresis timing of peripheral blood stem cells. Br J Haematol 1999 ; 106: 538 ‐ 44.
25. 25 Auer RL, Holtom P, Smith H, et al. Circulating CD34+ counts and apheresis planning. Hematol Oncol 1998 ; 16: 69 ‐ 75.
26. 26 Teshima T, Sunami K, Bessho A, et al. Circulating immature cell counts on the harvest day predict the yields of CD34+ cells collected after granulocyte colony‐stimulating factor plus chemotherapy‐induced mobilization of peripheral blood stem cell. Blood 1997 ; 89: 4660 ‐ 1.
27. 27 Demirer T, Buckner CD, Gooley T, et al. Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. Bone Marrow Transplant 1996 ; 17: 937 ‐ 41.
28. 28 Kotasek D, Shepherd KM, Sage RE, et al. Factors affecting blood stem cell collections following high‐dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant 1992 ; 9: 11 ‐ 7.
29. 29 Prince HM, Imrie K, Sutherland DR, et al. Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collections. Br J Haematol 1996 ; 93: 142 ‐ 5.
30. 30 Goldschmidt H, Hegenbart U, Wallmeier M, et al. Factors influencing collection of peripheral blood progenitor cells following high‐dose cyclophosphamide and granulocyte colony‐stimulating factor in patients with multiple myeloma. Br J Haematol 1997 ; 98: 736 ‐ 44.
31. 31 Drake M, Ranaghan L, Morris TC, et al. Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system. Br J Haematol 1997 ; 98: 745 ‐ 9.
32. 32 Moskowitz CH, Glassman JR, Wuest D, et al. Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma. Clin Cancer Res 1998 ; 4: 311 ‐ 6.
33. 33 Dreger P, Kloss M, Petersen B, et al. Autologous progenitor cell transplantation. prior exposure to stem cell‐toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood 1995 ; 86: 3970 ‐ 8.
34. 34 Demirer T, Buckner CD, Storer B, et al. Effect of different chemotherapy regimens on peripheral‐blood stem‐cell collections in patients with breast cancer receiving granulocyte colony‐stimulating factor. J Clin Oncol 1997 ; 15: 684 ‐ 90.
35. 35 Ketterer N, Salles G, Moullet I, et al. Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies. Br J Haematol 1998 ; 103: 235 ‐ 42.
36. 36 Remacha AF, Martino R, Sureda A, et al. Changes in reticulocyte fractions during peripheral stem cell harvesting: role in monitoring stem cell collection. Bone Marrow Transplant 1996 ; 17: 163 ‐ 8.